Reproxalap Ophthalmic Solution (0.5%)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisNCT03494504ALDXPhase 3Completed2018-11-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.